Graphique du cours de l'action APUS
APUS Prévision du cours des actions
Apimeds Pharmaceuticals US Inc
$0
0%
$0
À la fermeture : Jun 26, 16:00:00 GMT-4
$0
0%
$0
Post-Marché: Jun 26, 19:44:35 GMT-4
Retour
Apimeds Pharmaceuticals US Inc (APUS) Prévision du cours des actions
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
Rendement en dividend
--
BPA (TTM)
--
Capitalisation boursière
--
Qu’est-ce que APUS ?
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
Fonctionnalités
© 2026 Edgen fonctionné par